HENRY SCHEIN INC

NASDAQ: HSIC (Henry Schein, Inc.)

Last update: 3 hours ago

70.74

-0.10 (-0.14%)

Previous Close 70.84
Open 70.65
Volume 576,184
Avg. Volume (3M) 1,868,960
Market Cap 8,784,280,576
Price / Earnings (TTM) 23.19
Price / Earnings (Forward) 14.60
Price / Sales 0.710
Price / Book 2.59
52 Weeks Range
63.67 (-9%) — 82.49 (16%)
Earnings Date 5 May 2025 - 9 May 2025
Profit Margin 3.08%
Operating Margin (TTM) 4.86%
Diluted EPS (TTM) 3.05
Quarterly Revenue Growth (YOY) 5.80%
Quarterly Earnings Growth (YOY) 422.20%
Total Debt/Equity (MRQ) 59.40%
Current Ratio (MRQ) 1.42
Operating Cash Flow (TTM) 848.00 M
Levered Free Cash Flow (TTM) 800.37 M
Return on Assets (TTM) 4.49%
Return on Equity (TTM) 7.97%

Market Trend

Short Term Medium Term
Industry Medical Distribution (US) Mixed Mixed
Medical Distribution (Global) Mixed Mixed
Stock Henry Schein, Inc. Bullish Bearish

AIStockmoo Score

1.2
Analyst Consensus 3.0
Insider Activity 3.0
Price Volatility 2.0
Technical Moving Averages -1.5
Technical Oscillators -0.5
Average 1.20

Similar Stocks

Stock Market Cap DY P/E (TTM) P/B
HSIC 9 B - 23.19 2.59
ZYXI 94 M - 32.83 6.53
PDCO 3 B 2.50% 20.38 2.78
EDAP 83 M - - 1.81
COSM 11 M - - 0.360
AHG 494 M - - 3.89

Henry Schein Inc is a solutions company for healthcare professionals powered by a network of people and technology. The company is a provider of healthcare products and services primarily to office-based dental and medical practitioners, as well as alternate sites of care. The company operates in two reportable segments; health care distribution and technology & value-added services. The healthcare distribution segment is engaged in combining global dental and medical businesses and distributes consumable products, small equipment, laboratory products, and Vitamins. The technology and value-added services reportable segment provides software, technology & other value-added services to health care practitioners. The majority of revenue is derived from the health care distribution segment.

Sector Healthcare
Industry Medical Distribution
Investment Style Small Core
% Held by Insiders 1.06%
% Held by Institutions 115.73%

Ownership

Name Date Shares Held
Palestra Capital Management Llc 31 Dec 2024 2,644,336
Southpoint Capital Advisors Lp 31 Dec 2024 2,600,000
52 Weeks Range
63.67 (-9%) — 82.49 (16%)
Price Target Range
80.00 (13%) — 90.00 (27%)
High 90.00 (Barrington Research, 27.23%) Buy
Median 80.00 (13.09%)
Low 80.00 (Wells Fargo, 13.09%) Hold
80.00 (UBS, 13.09%) Hold
80.00 (Jefferies, 13.09%) Hold
Average 82.80 (17.05%)
Total 2 Buy, 3 Hold
Avg. Price @ Call 73.52
Firm Date Target Price Call Price @ Call
Barrington Research 26 Feb 2025 90.00 (27.23%) Buy 72.55
30 Jan 2025 90.00 (27.23%) Buy 80.03
UBS 26 Feb 2025 80.00 (13.09%) Hold 72.55
Wells Fargo 14 Feb 2025 80.00 (13.09%) Hold 76.00
Jefferies 23 Jan 2025 80.00 (13.09%) Hold 74.75
B of A Securities 06 Jan 2025 84.00 (18.74%) Buy 71.76
Name Avg. Buy ($) Avg. Sell ($) Net Quantity Net Value ($)
ALBERTINI ANDREA 75.45 - 21,206 1,599,993
BERGMAN STANLEY M 75.45 - 102,913 7,764,786
BRESLAWSKI JAMES P 75.45 - 3,313 249,966
ETTINGER MICHAEL S 75.45 - 26,507 1,999,953
MLOTEK MARK E 75.45 74.59 25,797 1,946,994
POPECK THOMAS C 75.45 - 14,247 1,074,936
SIEGEL WALTER 75.45 - 9,609 724,999
SOUTH RONALD N. 75.45 - 19,880 1,499,946
Aggregate Net Quantity 223,472
Aggregate Net Value ($) 16,861,573
Aggregate Avg. Buy ($) 75.45
Aggregate Avg. Sell ($) 74.59
Name Holder Date Type Quantity Price Value ($)
ALBERTINI ANDREA Officer 10 Mar 2025 Acquired (+) 21,206 75.45 1,599,993
POPECK THOMAS C Officer 10 Mar 2025 Acquired (+) 14,247 75.45 1,074,936
SIEGEL WALTER Officer 10 Mar 2025 Acquired (+) 9,609 75.45 724,999
SOUTH RONALD N. Officer 10 Mar 2025 Acquired (+) 19,880 75.45 1,499,946
BERGMAN STANLEY M Officer 10 Mar 2025 Acquired (+) 102,913 75.45 7,764,786
BRESLAWSKI JAMES P Officer 10 Mar 2025 Acquired (+) 3,313 75.45 249,966
ETTINGER MICHAEL S Officer 10 Mar 2025 Acquired (+) 26,507 75.45 1,999,953
MLOTEK MARK E Officer 10 Mar 2025 Acquired (+) 26,507 75.45 1,999,953
MLOTEK MARK E Officer 07 Mar 2025 Disposed (-) 710 74.59 52,959
Date Type Details
12 Mar 2025 Announcement Henry Schein Donates Health Care Products to Support Special Olympics Healthy Athletes® Screenings at Special Olympics World Winter Games 2025 in Turin, Italy
11 Mar 2025 Announcement Ethisphere Names Henry Schein as One of the 2025 World's Most Ethical Companies® for 14th Consecutive Year
03 Mar 2025 Announcement Henry Schein to Participate in Upcoming Investor Conference in March
26 Feb 2025 Announcement Nominations Now Open for Henry Schein Medical’s Athletics and Schools 2025 Rising Star Award
25 Feb 2025 Announcement Henry Schein Reports Fourth Quarter and Full Year 2024 Financial Results and Provides Detailed 2025 Financial Guidance
12 Feb 2025 Announcement Henry Schein Chairman and CEO Stanley M. Bergman Receives National Association of Wholesaler-Distributors Dirk Van Dongen Lifetime Achievement Award
10 Feb 2025 Announcement Give Kids A Smile Program Celebrates 23rd Year of Providing Free Oral Health Care Services to Underserved Children
05 Feb 2025 Announcement Henry Schein Medical Honors Women Trailblazers in Athletic Training on National Girls and Women in Sports Day 2025
29 Jan 2025 Announcement Henry Schein Announces Strategic Investment by KKR, Board Changes and Provides Preliminary Unaudited Financial Results and 2025 Financial Guidance
23 Jan 2025 Announcement Henry Schein to Webcast Fourth Quarter and Full-Year 2024 Conference Call on Tuesday, February 25, 2025, at 8:00 a.m. ET
16 Jan 2025 Announcement Provident Healthcare Partners Advises Acentus in its Acquisition by Henry Schein
15 Jan 2025 Announcement Henry Schein Completes Acquisition of Acentus
14 Jan 2025 Announcement Henry Schein Opens Henry Schein Cares Foundation 2025 Relief Fund and Commits Up to $300,000 in Cash and Essential Health Care Supplies to Support the City of Los Angeles
09 Jan 2025 Announcement Henry Schein Opens Customer Emergency Support Hotline in Response to California Fires
Show more

The support, resistance and trendline levels presented has been generated by an artificial intelligence (AI) model and should be interpreted with caution.

Portfolio

AI Template

Your price alert

Risk Profile

| | | | |
Conservative
Moderate Conservative
Moderate
Moderate Aggressive
Aggressive
Margin of Safety (EP)
Partial Profit (TP1)
Target Profit (TP2)
Maximum Loss (SL)

Disclaimer: The above is for illustrative purposes only and is NOT investment advice. Seek advice from a qualified financial professional.

Entry Price (EP)

Take Profit 1 (TP1)

Take Profit 2 (TP2)

Stop Loss (SL)

52W Range
 
52WL
 
52WH
SL
EP
TP1
TP2

All alert prices are within 52 weeks price range

Realized Profit -
Unrealized Profit -
Dividend Received 2025 -
Total Profit -
Avg. Return -
Quantity (Buy) -
Avg. Price (Buy) -
Quantity (Sold) -
Avg. Price (Sold) -
No stocks matching your criteria